A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications. [PDF]
Hosp PharmMcCarville B, Osborn J.
europepmc +1 more source
Reply: RIVAWAR Trial Commentary: Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction. [PDF]
JACC AdvShah JA +3 more
europepmc +1 more source
Evaluation of postoperative bleeding and pain following tooth extraction in patients using direct oral anticoagulants: a prospective case-control study with blinded evaluation. [PDF]
BMC Oral HealthKaya İ.
europepmc +1 more source
Successful Treatment of Delayed Partial Flap Loss in Autologous Breast Reconstruction With Rivaroxaban. [PDF]
CureusBeck JH +4 more
europepmc +1 more source
Direct oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism among individuals with gastrointestinal cancer: an updated meta-analysis. [PDF]
Thromb JRen J, Li P.
europepmc +1 more source
Anticoagulation in Frail Older Adults with Non-Valvular Atrial Fibrillation: Clinical Challenges and Personalized Approach. [PDF]
J Clin MedFabbri E, Maestri L, Muratori P.
europepmc +1 more source
Left Ventricular Pseudoaneurysm Possibly Associated with Rivaroxaban Therapy Disappeared after Cessation of Rivaroxaban: Case Report and Literature Review. [PDF]
Surg Case RepKiryu K +7 more
europepmc +1 more source
Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation. [PDF]
Ann Lab MedPark JS +5 more
europepmc +1 more source
Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study. [PDF]
PLoS MedSun J, Mehta HB, Segal JB, Alexander GC.
europepmc +1 more source